SLAS Discovery

Papers
(The H4-Index of SLAS Discovery is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay120
SLAS special issue editorial 2022: 3D cell culture approaches of microphysiologically relevant models47
Bioassay protocol metadata annotation: Proposed standards adoption44
Ex vivo discovery of synergistic drug combinations for hematologic malignancies41
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei40
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery34
Protocol for 3D screening of lung cancer spheroids using natural products31
Genetically encoded fluorogenic RNA-based bioluminescence resonance energy transfer (BRET) sensors for cellular imaging and target detection29
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature27
Outline and background for the EU-OS solubility prediction challenge26
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening24
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies23
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling22
Emerging drug discovery ecosystems22
Role Of Vaccines Against COVID-19 Pandemic21
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin19
Drug repurposing screen for the rare disease ataxia-telangiectasia18
Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells17
0.06485390663147